Tourmaline Bio
Social media
Tourmaline Bio Logo
About Tourmaline Bio
Tourmaline Bio Inc is a clinical-stage biotechnology company focused on developing transformative medicines for patients with life-altering immune and inflammatory diseases. Its lead candidate, TOUR006, is a human anti-IL-6 monoclonal antibody targeting interleukin-6, a key cytokine in autoimmune and inflammatory disorders. The company's pipeline includes therapies for atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED), aiming to address areas of high unmet medical need.
Address
27 West 24th Street, Suite 702
New York, 10010
United States
Year founded
2002
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
